Searching online for “private cortisone injections near me” is often where the decision-making process begins, but it rarely tells you what you actually need to know before booking an appointment. With four distinct intra-articular therapies now available, including corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and the newer polyacrylamide option Arthrosamid, the question is no longer simply whether to have a knee injection. The real question is which one suits your specific circumstances.
The answer depends on factors that a search result cannot determine for you: the severity of your osteoarthritis, your activity level, how quickly you need relief, and what your budget allows. Each therapy has a defined role, a patient profile it serves best, and a set of limitations that matter enormously in practice.
This guide works through each option in clinical terms, compares them directly, and gives you a structured framework for self-qualification before you speak with a specialist. By the end, you will understand not just what each injection does, but whether it is likely to be the right choice for you specifically.
Why There Is No Single Best Knee Injection
Four intra-articular therapies are used to treat knee osteoarthritis: corticosteroid (cortisone), hyaluronic acid, platelet-rich plasma (PRP) and Arthrosamid. Each works through a fundamentally different biological mechanism, is supported by a different evidence base, and is appropriate for a different patient profile.
That last point is not a caveat; it is the clinical reality. A 2025 retrospective cohort study published in Medicine (Baltimore) directly compared PRP, hyaluronic acid, corticosteroids and NSAIDs for knee osteoarthritis and found that no single modality outperformed all others across every patient group. The emerging consensus in 2025 is clear: one-size-fits-all injection selection is clinically obsolete.
The right choice depends on at least five variables:
- OA severity, classified by Kellgren-Lawrence grade on imaging
- Activity level and functional goals, from daily mobility to competitive sport
- Timeline expectations, whether you need relief in days or can wait weeks for a more durable outcome
- Duration of effect required, spanning weeks to potentially two years depending on the intervention
- Budget, including how upfront cost relates to cost-per-month of benefit over time
Selecting an injection based on cost or convenience alone, without matching it to your clinical profile, is how patients end up disappointed and how repeat injections become necessary. If you have already been recommended a specific option and want to understand the evidence behind it, our guide to hyaluronic acid knee injections and what the clinical research actually shows is a useful starting point.
This piece provides a framework for self-qualification before a specialist appointment. It is not a substitute for one. The clinical decision still requires accurate diagnosis, imaging review and a structured treatment plan tailored to your specific presentation.
Understanding OA Severity: The Starting Point for Every Decision
The Kellgren-Lawrence (KL) grading system provides the standardised radiological framework, running from Grade 1 (minor osteophytes, no joint space narrowing) through to Grade 4 (severe narrowing, bone-on-bone contact). Where you sit on that scale directly shapes which injections are viable.
Mild OA (KL 1-2) offers the broadest treatment window. Joint space is preserved, synovial tissue is still functional, and regenerative options such as PRP and hyaluronic acid have a viable biological environment to work within. Tissue-level interventions make clinical sense at this stage precisely because there is still tissue worth supporting.
Moderate OA (KL 3) is the most contested clinical ground. Cortisone can deliver faster symptomatic relief, which matters when pain is limiting daily function or physiotherapy engagement. PRP and hyaluronic acid may offer longer-lasting functional improvement for the right patient, but the evidence is less uniform at this grade, and individual factors carry greater weight in the decision.
Severe OA (KL 4) narrows the injection field significantly. Most regenerative options show limited efficacy when joint space is critically reduced; the biological substrate for tissue-level response is largely absent. At this stage, injections are more appropriately directed at symptom management while surgical options are assessed and planned.
Identifying your KL grade requires imaging, specifically a weight-bearing X-ray, with diagnostic ultrasound added where soft tissue assessment is clinically indicated. Booking an injection without that diagnostic foundation is where mismatches happen. For a broader view of how OA severity maps to the full range of treatment options, including non-injection pathways, the complete guide to knee osteoarthritis treatment covers the evidence in full.
At PSM, the pathway begins with accurate diagnosis before any recommendation is made. Grade determines options; options then depend on the patient.
Corticosteroid Injections: Fast Relief With a Defined Window
Corticosteroids suppress the local inflammatory cascade within the joint, which is why they work so quickly. Pain and swelling typically begin to reduce within the first few days of injection, making them the most time-efficient option when function needs to be restored rapidly.
The evidence base for short-term efficacy is robust. A systematic review of Level I studies confirms a reliable relief window of 4 to 12 weeks. A meta-analysis of 12 randomised controlled trials covering 1,794 patients found corticosteroids statistically superior to hyaluronic acid at one month (p=0.03), equivalent at three months, and inferior by six months, when HA became the more effective option. That trajectory is clinically important: cortisone’s value is front-loaded.
Repeated high-frequency use carries a different risk profile. There is established concern around potential cartilage thinning and progressive loss of treatment response with frequent dosing in weight-bearing joints, which is why corticosteroids are best used strategically rather than routinely.
Who is the right candidate?
Cortisone is best suited to patients experiencing an acute inflammatory flare, those with moderate pain that is limiting engagement with physiotherapy, and individuals who need short-term relief ahead of a specific functional goal or event. Patients with inflammatory arthropathy, rather than purely mechanical OA, often respond particularly well. It is not a regenerative treatment; it does not alter the underlying disease course, and should not be framed as one.
Delivery method matters
Cortisone should ideally be administered under ultrasound guidance. Imaging-guided placement significantly improves accuracy of intra-articular delivery compared to landmark-based technique, reducing the risk of peri-articular complications and improving the reliability of the outcome. At PSM, all corticosteroid injections are delivered under ultrasound guidance as standard.
Cost in context
Private cortisone injection costs in the UK vary by provider and whether ultrasound guidance is included; confirm costs directly with the clinic. Patients comparing providers on cost alone should confirm whether imaging guidance is part of the procedure, as it directly affects both accuracy and safety.
Hyaluronic Acid Injections: Viscosupplementation for the Active Patient
Where cortisone targets inflammation directly, hyaluronic acid (HA) works through a different mechanism entirely. Viscosupplementation replenishes the synovial fluid’s natural lubricating and shock-absorbing properties, which progressively degrade as osteoarthritis advances. The action is mechanical and biological rather than anti-inflammatory; HA is not designed to resolve an acute flare but to restore the joint environment gradually over a 4 to 8 week window post-injection.
Who is this best suited to?
The strongest candidate profile is mild-to-moderate OA (Kellgren-Lawrence grades 1 to 3), particularly active individuals seeking to maintain function and delay surgical intervention. HA is also a logical next step for patients who have had an adequate but short-lived response to cortisone and want a longer duration of effect, typically in the region of 6 to 12 months.
NHS availability and the evidence position
Patients researching what is the new injection for knee pain on the NHS frequently encounter HA for the first time, only to discover it sits outside standard NHS provision. NICE guidelines do not currently recommend hyaluronic acid injections for knee osteoarthritis, meaning this is predominantly a private treatment option in the UK. A 2022 BMJ meta-analysis of 169 trials found only a small reduction in pain versus placebo, with the effect described as clinically marginal in later high-quality trials. The evidence is most consistent for mild-to-moderate OA; in advanced joint degeneration, the rationale weakens further.
For a more detailed review of the mechanism, evidence and patient selection criteria, the PSM clinical guide to hyaluronic acid injections for joint health covers these considerations in full.
Cost and practical considerations
Hyaluronic acid injection costs in the UK vary by product type, whether a single or multi-dose protocol is used, and the clinical setting; confirm current pricing directly with the clinic. Hyaluronic acid injections cost is among the most common pre-consultation queries PSM receives, and the answer depends on which formulation and delivery protocol is clinically appropriate for that individual.
The key limitation to set expectations around is onset. Unlike cortisone, HA requires patience; the full effect develops over several weeks, making it unsuitable for patients who need rapid relief.
PRP Injections: Harnessing the Body’s Own Healing Response
Where hyaluronic acid works mechanically, replenishing what the joint has lost, PRP works biologically, using the body’s own signalling chemistry to do something more fundamental.
PRP is prepared by drawing a small volume of the patient’s own blood and processing it through centrifugation. This concentrates the platelets and their associated growth factors and bioactive proteins into a therapeutic dose that is then injected directly into the joint. The result is not lubrication or anti-inflammatory suppression; it is a concentrated biological signal that may support cartilage health, modulate the chronic inflammatory environment and encourage tissue-level repair over time. For a fuller explanation of the preparation process and clinical application, the PSM guide on what PRP injection therapy involves and how it works covers this in detail.
The evidence base is strengthening. A 2024 systematic review and meta-analysis found PRP showed superior WOMAC improvement at mid- and long-term follow-ups, exceeding minimal clinically important difference thresholds, particularly for younger, more active patients with mild-to-moderate OA where preserving joint tissue carries greater long-term functional value than simply controlling symptoms.
Who PRP Suits Best
The strongest candidates are active individuals under 65 with mild-to-moderate OA (KL Grade 1-3), particularly those whose primary goal is maintaining sporting activity rather than managing daily pain alone. PRP also suits patients who have had limited or short-lived benefit from cortisone or hyaluronic acid and are looking for a more durable, biologically active option. The critical requirement is timeline tolerance: effect builds over several weeks, so PRP is not appropriate where rapid relief is the priority.
Limitations and Honest Expectations
Individual response varies, and some patients require more than one injection in an initial course. The preparation process is more involved than a standard injection appointment. PRP is not a quick fix, and patients who approach it expecting cortisone-speed results are likely to be disappointed. Setting realistic expectations before proceeding is essential.
Cost context: PRP injection costs in the UK vary depending on preparation method, clinical setting and whether ultrasound guidance is used; confirm current pricing directly with the clinic. It is the most involved of the three conventional options covered so far, and carries the longest evidence-supported duration of effect among them.
Arthrosamid: The Newer Polyacrylamide Option Explained
Where PRP relies on your own biology and hyaluronic acid on mechanical lubrication, Arthrosamid works differently to both, and that distinction matters when choosing the right option.
Arthrosamid is a non-biodegradable polyacrylamide hydrogel: a synthetic gel composed of 97.5% water injected directly into the knee joint. Rather than being resorbed like hyaluronic acid or acting within a finite biological window like PRP, it integrates with the synovial tissue and remains in the joint long term. The clinical rationale is to provide sustained cushioning, reduce friction and modulate the inflammatory environment of the joint over an extended period.
A peer-reviewed 12-month follow-up study from the Parker Institute and Leeds Institute of Rheumatic and Musculoskeletal Medicine confirmed improvements in pain, stiffness and physical function. Separately, evaluation data report clinical effects maintained for at least four years in appropriate candidates. A comparative cohort study found no significant difference between Arthrosamid, corticosteroid and hyaluronic acid at three months; however, at six months, Arthrosamid showed greater improvement than corticosteroid. The evidence base is still maturing, and well-designed long-term trials continue to build on early findings.
Regulatory status and NHS access
Arthrosamid holds CE marking and is available in the UK as a private treatment. It does not currently have NICE approval for NHS use, so patients asking about the new injection for knee pain on the NHS should be aware it is only accessible through specialist private clinics. For a fuller overview of how it works and what to expect, our dedicated guide to Arthrosamid covers the treatment in detail.
Who is it best suited to?
The clearest candidates are patients with moderate OA (Kellgren-Lawrence Grade 2-3) who have had insufficient or short-lived relief from other injections, those looking to delay surgical intervention, and those who prefer a single-injection approach without a planned repeat schedule.
It is not appropriate for Grade 4 (bone-on-bone) OA or where active joint infection is present. As the highest-cost single injection option, patient selection is particularly important.
At PSM, Arthrosamid is administered under ultrasound guidance by a specialist sports medicine doctor. Given its non-biodegradable nature, precise intra-articular placement is not optional; it is essential to both safety and efficacy.
Comparison Matrix: Matching Each Injection to the Right Patient
With each injection now profiled individually, the table below draws the comparisons together into a single decision framework.
| Cortisone | Hyaluronic Acid | PRP | Arthrosamid | |
|---|---|---|---|---|
| Onset | Days | 2-4 weeks | 4-8 weeks | 4-8 weeks |
| Duration | 4-12 weeks | 6-12 months | Medium-to-long term; individual response varies | Up to 2 years+ |
| OA severity | All grades; KL4 symptom management | KL 1-3 | KL 1-3 | KL 2-3; preserved joint space required |
| Activity fit | Pain management; pre-physio bridge | Active; function maintenance | Athletes; return-to-sport goal | Structural support; longer-term durability |
| Typical private cost | Confirm with clinic | Confirm with clinic | Confirm with clinic | Confirm with clinic |
| NHS availability | Some pathways | Privately funded in most cases | Private only | Private only |
OA severity is the first filter. Mild OA keeps all four options viable. Moderate OA opens the full range, and clinical decision-making becomes most nuanced here. Severe, bone-on-bone OA narrows the field to cortisone for symptom control while surgical planning proceeds; regenerative options and Arthrosamid are not appropriate at KL4.
Activity level is the second filter. Athletes and active individuals with a return-to-sport goal tend to align best with PRP, where the biological response supports tissue health over time, or with Arthrosamid where structural joint support is the priority. Patients whose primary need is daily pain reduction rather than functional performance often respond well to cortisone or, where lubrication is the limiting factor, hyaluronic acid. For a clinically grounded overview of when hyaluronic acid injections can restore the natural cushioning lost in arthritic joints, the PSM evidence guide covers patient selection in detail.
Budget, assessed over time rather than upfront, changes the calculation considerably. As noted in the individual profiles above, the cost-per-month picture across modalities can differ significantly from the upfront figure alone; it is worth running that calculation before dismissing the higher-cost options on sticker price alone. The private clinic value proposition extends beyond which injection is selected. Specialist diagnosis, ultrasound-guided delivery, and integrated rehabilitation are what determine whether the intervention actually works.
Why Injection Alone Is Rarely the Complete Answer
Selecting the right injection is only part of the clinical decision. Whichever modality is chosen, the evidence base supporting multimodal management is clear: an injection creates a window of improved joint environment, but it is structured physiotherapy that converts that window into durable functional gains. Without appropriate load progression through rehabilitation, the joint returns to the same mechanical and neuromuscular deficits that contributed to symptom onset.
Guidelines consistently identify concurrent rehabilitation as a determinant of sustained outcomes; injection as a standalone intervention does not address the mechanical and neuromuscular deficits that contributed to symptoms. The injection reduces pain and improves the joint environment; physiotherapy is what builds the capacity to maintain that improvement.
Understanding what genuine multidisciplinary physiotherapy care looks like is particularly relevant for active patients, where returning to sport or training requires more than pain reduction alone.
For active individuals especially, multidisciplinary input changes the standard of care meaningfully. A sports medicine doctor leading the injection decision, a musculoskeletal radiologist confirming imaging findings, and a specialist physiotherapist delivering load-progression rehabilitation represents a fundamentally different clinical model than a procedure delivered in isolation.
Before committing to any provider, patients should ask three direct questions:
- Is the injection delivered under ultrasound guidance?
- Is there a structured rehabilitation plan following the procedure?
- Who is responsible for monitoring my progress?
These questions reliably distinguish specialist, integrated care from high-volume private injection services where the procedure ends at the clinic door.
A Self-Qualification Framework Before Your Consultation
Knowing which questions to ask is half the work. Before you book a consultation, working through the following five points will sharpen the conversation considerably.
1. How severe is your OA? If you have had imaging, identify your Kellgren-Lawrence (KL) grade. If you have not, a diagnostic assessment including a weight-bearing X-ray should be your first step. Booking an injection without knowing your KL grade is working blind; the grade directly influences which options are clinically appropriate.
2. What is your primary goal? Rapid pain relief to manage daily function, maintaining sporting activity, buying time before surgery, or a longer-term structural solution each point to a different injection profile. Cortisone suits the first; PRP or Arthrosamid typically suit the third and fourth. Being clear on this before your appointment prevents a mismatch between expectation and outcome.
3. What is your timeline? If you need meaningful relief within days for a specific event or commitment, cortisone is the most appropriate bridge. If you can allow several weeks for effect to build, PRP or Arthrosamid offer considerably greater durability for the right patient. Timeline is not a minor preference; it is a clinical variable.
4. What is your budget, and how do you think about cost per month of relief? Upfront cost is rarely the correct lens. A modality with a higher single-procedure cost but a longer duration of effect may represent better value per month of relief than a lower-cost option repeated several times a year. Your specialist can provide current pricing for each option at your consultation.
5. Have you had previous injections? If so, note which type, how quickly they worked, and how long the benefit lasted. Prior response history is one of the most useful clinical data points available; a specialist will use it to refine the recommendation rather than starting from scratch.
Arriving at a PSM consultation with clear answers to these five questions transforms the appointment into a structured, evidence-informed decision rather than an exploratory conversation. That preparation is what makes specialist input genuinely valuable.
How PSM Approaches Knee Injection Decision-Making
Those five questions above are most useful when brought into a consultation structured to act on them. That is precisely how PSM operates.
At Pro Sports Medicine in Cardiff, no injection is recommended without a prior diagnostic assessment. Every patient follows the PSM Pathway: clinical examination first, imaging review where indicated, then a treatment decision grounded in an accurate understanding of what is actually happening in the joint. The injection is never the starting point.
PSM’s sports medicine doctors have worked at professional sport level, where the question is never simply “will this reduce pain?” The clinical standard is whether an intervention optimises the patient’s capacity to return to performance, under appropriate oversight. That same standard applies to every patient seen at the clinic, whether a competitive athlete or an active person managing their first significant knee problem.
All four injection modalities covered in this guide, cortisone, hyaluronic acid, PRP and Arthrosamid, are available at PSM and administered under ultrasound guidance. Precise intra-articular placement is not incidental; it directly affects both clinical outcomes and safety, particularly for non-biodegradable agents such as Arthrosamid where accurate delivery is essential.
That integrated rehabilitation pathway, described above, is built in from the outset. PSM serves patients across Cardiff, South Wales and the West of England who require a level of musculoskeletal care that a standard GP referral pathway cannot provide. For active individuals and athletes in particular, functional outcomes matter as much as symptom reduction. That demands specialist diagnosis, expert injection technique and a rehabilitation framework working together, not independently.
Making the Right Choice Starts With the Right Assessment
The research is clear: no single knee injection is right for every patient. The correct choice depends on matching your OA severity, activity level, timeline, budget and functional goals to the right modality, within a clinical framework that includes imaging and structured decision-making.
Each modality’s distinct profile is set out in the comparison matrix above. Self-research has genuine value. Understanding these distinctions before your appointment means you arrive with the right questions, a clearer sense of your own priorities and a more productive conversation with your clinician. What it cannot replace is clinical assessment: imaging review, severity grading, response history and a structured treatment framework are what convert a general preference into an accurate recommendation.
PSM offers all four injection modalities as part of an integrated pathway that begins with diagnosis and ends with rehabilitation. If you are weighing your options and want a clear clinical recommendation grounded in your specific profile, rather than a general overview, a consultation with a PSM sports medicine doctor is the logical next step. Contact the clinic to book your assessment.
Conclusion
Choosing the right knee injection is not guesswork. It is a clinical decision shaped by four key realities: your OA severity determines your starting point; each modality serves a distinct patient profile; injection therapy works best within a broader rehabilitation framework; and accurate matching requires professional assessment, not general preference alone.
Cortisone, hyaluronic acid, PRP and Arthrosamid each have a legitimate place in knee care. The difference between a good outcome and a missed opportunity is whether the right option was selected for the right patient at the right stage.
You now have the knowledge to walk into that conversation prepared. The next step is acting on it. Book a consultation with a PSM sports medicine doctor, get a structured assessment and receive a recommendation built around your specific goals, not a generic protocol.
